Business Wire

CA-VISA-INC.

26.8.2020 14:02:07 CEST | Business Wire | Press release

Share
Visa Harnesses Real-Time Deep Learning to Enhance Transaction Processing

Visa Inc. (NYSE: V) today announced Visa Smarter Stand-in Processing (Smarter STIP), a new capability that uses real-time artificial intelligence (AI) to help financial institutions manage transaction authorizations when service disruptions occur. Using deep learning to analyze past transactions, Smarter STIP generates informed decisions to approve or decline transactions on behalf of issuers in the event that their systems go offline. Visa pioneered the use of AI and neural networks to prevent fraud—Smarter STIP builds on that track record, and is the first in a suite of new AI-powered innovations coming to VisaNet, Visa’s global processing network.

“Consumers expect instant and uninterrupted access to their funds—failure to meet that expectation can be costly,” says Jack Forestell, executive vice president and chief product officer, Visa. “Stand-in processing has always been a vital assurance to our clients that when the unexpected occurs, we’ve got their back. By adding AI, that capability becomes smarter, stronger, and more dynamic.”

Addressing the challenge of downtime

Whether it’s scheduled maintenance or an unexpected outage, service downtime is disruptive for financial institutions and their customers. When stand-in processing is not in place, the potential impacts can be profound: lost revenue due to failed transactions, poor cardholder experience resulting in call volume spikes to customer service centers, damage to reputation, and even scrutiny from regulators.

Visa’s new Smarter STIP service builds on Visa’s existing STIP capability by using deep learning to analyze past transactions down to the cardholder level. Thus the transaction decision that Smarter STIP provides is based on unique insights derived from the cardholder’s past purchasing behavior, rather than solely on static rules applied across an entire card portfolio. With this added intelligence, Visa is able to provide a transaction decision on the issuer’s behalf that more closely mirrors the issuer’s own decision making process—with the potential to decrease transaction declines for cardholders by up to 50% in some cases.1

Harnessing AI for the Payments Ecosystem

Visa Smarter STIP is one of several new real-time deep learning capabilities designed to solve long-standing challenges and pain points for buyers, sellers, and financial institutions.

These enhanced services are made possible by the investments Visa has made to optimize its core infrastructure. This includes a scalable, high-performing, GPU-based platform designed to support the rapid deployment of deep learning capabilities.

“AI is one of the most transformative technologies of our time, giving us the power to build data-driven products that deliver new levels of insight and personalization. With one of the largest and richest data sets in the world, Visa is extremely well positioned to unlock the full potential of AI for our clients and cardholders, and at massive scale,” says Rajat Taneja, president of technology at Visa. “We’ve made significant investments in our infrastructure, making it possible to harness this data more deeply across all facets of VisaNet. Our data, combined with low-latency architecture and our unique modeling capabilities, make our technology platform among the most powerful for AI.”​

Global adoption already underway

Smarter STIP will be available in October 2020 and has generated interest from a range of financial institutions around the world.

“At UBS, we believe in building a better future for our customers by harnessing the power of innovation and collaboration—a continuous process that relies on innovative thinking and transformative technologies and capabilities, developed both in-house and by our partners,” says Stefan Uebelhart, Head of UBS Card Center. “We are very pleased to launch Visa’s Smarter STIP service, as this is an example where the power of collaboration, transformative technologies and innovation come together to provide an improved experience for our cardholders. In our quest to build a better future for our customers, we see Visa as a valued partner and intend to work together in the innovation space.”

“As a leader in interest-free shopping platforms in Australia and New Zealand, Latitude Financial is constantly exploring new technology and innovation so we can deliver the best possible service to our customers,” said Latitude’s Chief Commercial Officer, Paul Varro. “Visa’s Smarter STIP service helps us substantially improve transaction approval rates. This is a great outcome, cleverly bringing together AI with our historical authorisation learnings, new datasets, and Visa’s experience in transaction processing to provide a rich customer experience, all the time.”

About Smarter STIP

Visa created the Smarter STIP capability to address a key pain point for issuers and issuer processors: the suboptimal experience for cardholders during service disruptions. Visa’s novel approach to stand-in processing, recognized through a US Patent in 2019, improves on the existing STIP capability through real-time evaluation of cardholder-level features. The model relies on:

  • Multiple recurrent neural network layers with millions of parameters.
  • Billions of historical records to train the model, resulting in an average 95% accuracy in emulating an issuer’s likely decision in Visa’s sample tests2 .
  • Continuous learning from real time transaction and outage data, allowing the service to adapt and improve as an Issuers’ behavior changes over time​.

Visa Smarter STIP does not require any technical change for clients to participate. Issuers connected to Visa DPS will be enabled for Smarter STIP when the service launches globally in October 2020.

About Visa Inc.

Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device for everyone, everywhere. As the world moves from analog to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa , visa.com/blog and @VisaNews .


1 Based on Visa internal analysis comparing existing and Smarter STIP approval rates of all transactions in Q1 CY2020 for a single US Issuer.
2 This number was measured by Visa’s internal simulation of the Smarter STIP model offline on transactions for all Visa BINs globally in Q4 2019. On average, the Smarter STIP model made the same approve/decline decision as the issuers 95% of the time, for transactions across all regions.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye